# Cerebral-Protected Percutaneous Thrombectomy for Near-Occlusive LVAD Outflow Graft Thrombosis

**Authors:** Teja S. Chakrala, Toochukwu Tanko, Vikram Raje, Lawrence Charles, Matthew Janko, R. Kyle Thompson, Ronnie Ramadan, Ugochukwu O. Egolum

PMC · DOI: 10.1016/j.jaccas.2025.106069 · JACC Case Reports · 2026-01-28

## TL;DR

A 70-year-old man with a HeartMate 3 LVAD experienced a life-threatening outflow graft blockage, successfully treated with a minimally invasive procedure that restored normal device function.

## Contribution

This case highlights a successful, minimally invasive treatment for LVAD outflow graft thrombosis using cerebral-protected thrombectomy.

## Key findings

- Computed tomographic angiography revealed >90% thrombotic narrowing of the distal outflow graft.
- Percutaneous cerebral-protected thrombectomy restored complete graft patency and device flow to 4 L/min.
- Early imaging-guided intervention can safely treat outflow graft thrombosis and avoid emergent pump exchange.

## Abstract

Late low-flow alarms in left ventricular assist devices (LVADs) most commonly result from volume depletion or right-sided failure, but mechanical outflow graft obstruction is an infrequent yet life-threatening cause.

A 70-year-old man with a HeartMate 3 LVAD presented with persistent low-flow (0 L/min) alarms after defecation but felt entirely well. Laboratory testing showed no overt hemolysis, and transthoracic echocardiography excluded right-sided failure. Computed tomographic angiography revealed >90% thrombotic narrowing of the distal outflow graft. The patient underwent percutaneous cerebral-protected thrombectomy with a Penumbra aspiration catheter followed by serial balloon dilatations (8-18 mm) achieving complete graft patency and immediate restoration of device flow to 4 L/min.

Outflow graft thrombosis occurs in approximately 2% to 5% of contemporary LVAD recipients and carries high morbidity if untreated. Few reports describe successful catheter-directed thrombectomy; this case highlights prompt multimodality imaging, a heart-team approach, and the utility of cerebral protection to mitigate embolic risk.

Persistent low-flow alarms mandate systematic evaluation. Early imaging-guided intervention can safely rescue outflow graft thrombosis and avoid emergent pump exchange.

## Linked entities

- **Diseases:** thrombosis (MONDO:0000831)

## Full-text entities

- **Genes:** HP (haptoglobin) [NCBI Gene 3240] {aka HP2ALPHA2, HPA1S}
- **Diseases:** hyperlipidemia (MESH:D006949), infection (MESH:D007239), stroke (MESH:D020521), syncopal episode (MESH:D013575), dyspnea (MESH:D004417), stenosis (MESH:D003251), carotid artery disease (MESH:D002340), Thrombosis (MESH:D013927), blood loss (MESH:D016063), RV failure (MESH:D051437), embolic (MESH:D004617), seizures (MESH:D012640), fatigue (MESH:D005221), hemolysis (MESH:D006461), ventricular tachycardia (MESH:D017180), HM3 (MESH:C537153), seizure disorder (MESH:D004827), bleeding (MESH:D006470), systolic and diastolic heart failure (MESH:D054144), pulmonary hypertension (MESH:D006976), melena (MESH:D008551), neurologic deficit (MESH:D009461), tamponade (MESH:D002305), atrial fibrillation (MESH:D001281), restenosis (MESH:D023903), chest pain (MESH:D002637), edema (MESH:D004487), outflow obstructions (MESH:D014694), heart failure (MESH:D006333), intracranial hemorrhage (MESH:D020300), chronic kidney disease (MESH:D051436), hematuria (MESH:D006417), hypovolemia (MESH:D020896), ischemic cardiomyopathy (MESH:D009202), neurologic complications (MESH:D002493)
- **Chemicals:** bisoprolol (MESH:D017298), Heparin (MESH:D006493), antiplatelet (-), creatinine (MESH:D003404), losartan (MESH:D019808), aspirin (MESH:D001241), oxygen (MESH:D010100), eplerenone (MESH:D000077545), levetiracetam (MESH:D000077287), warfarin (MESH:D014859), Milrinone (MESH:D020105)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12882339/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12882339/full.md

## References

9 references — full list in the complete paper: https://tomesphere.com/paper/PMC12882339/full.md

---
Source: https://tomesphere.com/paper/PMC12882339